arthoris Archives - Stem Cells Colombia
Medellin, Colombia. +57 310 881 9333

Mesenchymal Stem Cells from Wharton’s Jelly: A Promising Approach for Arthritis Treatment

Neck and Back Pain

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Arthritis, explained Arthritis, explained Wharton’s jelly stem cells for arthritis: what they may do Wear-and-tear arthritis and rheumatoid arthritis are different problems. Here is how umbilical cord stem cells may help each, and what the trials show. 5 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Osteoarthritis is mostly wear and local inflammation; rheumatoid arthritis is the immune system misfiring. Wharton’s jelly cells send signals that calm inflammation and support the joint’s own repair. Trials have shown less pain and better daily function. Arthritis has a way of setting the schedule. It decides how long you can stand at the stove, whether you take the stairs, and how you feel on a cold morning before the first coffee. If the usual options have stopped helping, you have probably read about stem cells from the umbilical cord. Here is what they are, how they may help the two most common kinds of arthritis, and what the studies actually found. Which arthritis is this about? Osteoarthritis is the common one. The cartilage that cushions the joint thins out, and the lining of the joint gets inflamed. Knees, hips, hands and shoulders are the usual suspects. Rheumatoid arthritis is different. The immune system attacks the lining of many joints at once, often the small joints of the hands and feet. One is a local problem; the other is a whole-body one. In plain wordsSynovium the thin lining inside a joint that makes its lubricating fluid, and the part that gets inflamed in arthritis What is Wharton’s jelly, and why use it? It is the soft, gel-like tissue that protects the blood vessels inside the umbilical cord. It is rich in mesenchymal stem cells, and after a healthy birth the cord is usually thrown away. These cells come from very young tissue and grow well in the lab. For you, that means no procedure to harvest cells from your own body. Stem Cells Colombia uses only Wharton’s jelly cells, never bone marrow or fat. How might the cells help an arthritic joint? Think of an inflamed joint as a room where the smoke alarm won’t stop ringing. The cells help switch off the alarm so the joint’s own cells can get back to maintenance. They calm inflammation by releasing signals that turn down the chemicals behind pain and swelling. They support repair with growth factors that help the tissue around the cartilage. They rebalance the immune response, which matters most in rheumatoid arthritis. In plain wordsImmunomodulation nudging the immune system back toward balance, instead of switching it off What have the studies found? In knee osteoarthritis, a randomized trial compared umbilical cord cells with hyaluronic acid. At one year, patients who got two rounds of cells had less pain than those in the hyaluronic acid group, with no serious side effects. A large review of 28 randomized trials found improvements in pain and daily function. In rheumatoid arthritis, a study giving umbilical cord cells by IV alongside usual medicines reported lower inflammation markers and disease scores at one and three years. A 2020 systematic review of in vivo studies in patients with rheumatoid arthritis found the treatment safe and well tolerated, with improvements in symptoms and lower inflammatory markers. MythStem cells regrow worn-out cartilage. Reality: The aim is to calm inflammation and support your body’s own repair. Trials show less pain and better function. Who could benefit most? For osteoarthritis, people with mild to moderate joint damage usually have the most to gain. A specialist reviews your imaging first, so your plan is designed for your joint. For rheumatoid arthritis, the goal is to work alongside your rheumatologist, not replace your medicines. Every IV protocol starts with cancer markers, for your safety. What this means for you Know which arthritis you have; the approach for one joint and for the whole body is different. Send recent X-rays or an MRI; the stage of the joint shapes your plan. Send your imaging or labs on WhatsApp for a free evaluation, with your plan and price in writing and no commitment. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care There are several randomized trials of mesenchymal cells in knee osteoarthritis, including one with umbilical cord cells. Together they point to improvements in pain and function. For rheumatoid arthritis, studies with umbilical cord cells are encouraging on safety and inflammation, with lower disease scores, and research is growing. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial · Stem Cells Translational Medicine, 2019 Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials · Clinical Rheumatology, 2026 Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study · Drug Design, Development and Therapy, 2019 Therapeutic Potential of Mesenchymal Stromal Stem Cells in Rheumatoid Arthritis: a Systematic Review of In Vivo Studies · Stem Cell Reviews and Reports, 2020 Bring your case The right doctor for your kind of arthritis For osteoarthritis, Dr. Diana Reyes applies the cells into the